Recall of anemia drug follows reports of allergic reactions, deaths

02/25/2013 | New York Times (tiered subscription model), The

Affymax and Takeda Pharmaceutical have recalled Omontys, or peginesatide, following reports of serious allergic reactions and three deaths. The drug is used to treat anemia in patients undergoing kidney dialysis. Three deaths and 16 other cases of severe reactions have been reported, according to the FDA.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC